Gestational hypertension and preeclampsia. ACOG practice bulletin summary, number 222. Obstet Gynecol. 2020;135:1492–5.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1–7.
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller A-B, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33.
Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398:341–54.
Article CAS PubMed Google Scholar
Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124:1094–112.
Article CAS PubMed Google Scholar
Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Ren Physiol. 2020;318:F1315–26.
Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15:275–89.
Article PubMed PubMed Central Google Scholar
Rätsep MT, Hickman AF, Maser B, Pudwell J, Smith GN, Brien D, et al. Impact of preeclampsia on cognitive function in the offspring. Behav Brain Res. 2016;302:175–81.
Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, et al. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am J Obstet Gynecol. 2022;226:S895–906.
Article CAS PubMed Google Scholar
Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–58.
Article CAS PubMed PubMed Central Google Scholar
Guerby P, Tasta O, Swiader A, Pont F, Bujold E, Parant O, et al. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2021;40:101861.
Article CAS PubMed PubMed Central Google Scholar
Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Asp Med. 2007;28:192–209.
Goltsman DSA, Sun CL, Proctor DM, DiGiulio DB, Robaczewska A, Thomas BC, et al. Metagenomic analysis with strain-level resolution reveals fine-scale variation in the human pregnancy microbiome. Genome Res. 2018;28:1467–80.
Article CAS PubMed PubMed Central Google Scholar
Di Simone N, Santamaria Ortiz A, Specchia M, Tersigni C, Villa P, Gasbarrini A, et al. Recent insights on the maternal microbiota: impact on pregnancy outcomes. Front Immunol. 2020;11:528202.
Article PubMed PubMed Central Google Scholar
Ahmadian E, Rahbar Saadat Y, Hosseiniyan Khatibi SM, Nariman-Saleh-Fam Z, Bastami M, Zununi Vahed F, et al. Pre-eclampsia: microbiota possibly playing a role. Pharmacol Res. 2020;155:104692.
Article CAS PubMed Google Scholar
Altemani F, Barrett HL, Gomez-Arango L, Josh P, David McIntyre H, Callaway LK, et al. Pregnant women who develop preeclampsia have lower abundance of the butyrate-producer Coprococcus in their gut microbiota. Pregnancy Hypertens. 2021;23:211–9.
Chen X, Li P, Liu M, Zheng H, He Y, Chen M-X, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut. 2020;69:513–22.
Article CAS PubMed Google Scholar
Miao T, Yu Y, Sun J, Ma A, Yu J, Cui M, et al. Decrease in abundance of bacteria of the genus Bifidobacterium in gut microbiota may be related to pre-eclampsia progression in women from East China. Food Nutr Res. 2021;65:5781. https://doi.org/10.29219/fnr.v65.5781.
Lv L-J, Li S-H, Li S-C, Zhong Z-C, Duan H-L, Tian C, et al. Early-onset preeclampsia is associated with gut microbial alterations in antepartum and postpartum women. Front Cell Infect Microbiol. 2019;9:224.
Article CAS PubMed PubMed Central Google Scholar
Chang Y, Chen Y, Zhou Q, Wang C, Chen L, Di W, et al. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia. Clin Sci (Lond). 2020;134:289–302.
Yu J, Zhang B, Miao T, Hu H, Sun Y. Dietary nutrition and gut microbiota composition in patients with hypertensive disorders of pregnancy. Front Nutr. 2022;9:862892.
Article PubMed PubMed Central Google Scholar
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7:E14.
Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722–9.
Article CAS PubMed Google Scholar
Burgess S, Thompson SG. Mendelian randomization: methods for causal inference using genetic variants: CRC Press; 2021.
Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51:600–5.
Article CAS PubMed PubMed Central Google Scholar
Xu Q, Ni J-J, Han B-X, Yan S-S, Wei X-T, Feng G-J, et al. Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study. Front Immunol. 2021;12:746998.
Article CAS PubMed Google Scholar
Inamo J. Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study. Ann Rheum Dis. 2021;80:e103.
Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53:156.
Article CAS PubMed PubMed Central Google Scholar
MiBioGen consortium. MiBioGen. https://mibiogen.gcc.rug.nl/. Accessed 16 Sep 2022.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner K, et al. FinnGen: unique genetic insights from combining isolated population and national health register data. medRxiv. 2022;2022.03.03.22271360. https://doi.org/10.1101/2022.03.03.22271360.
FinnGen. FinnGen R7 release. https://r7.finngen.fi/. Accessed 1 Oct 2022.
Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35:1880–906.
Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178:1177–84.
Article PubMed PubMed Central Google Scholar
Bowden J, Smith GD, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.
Article PubMed PubMed Central Google Scholar
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985–98.
Article PubMed PubMed Central Google Scholar
Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693–8.
Article CAS PubMed PubMed Central Google Scholar
Xue H, Shen X, Pan W. Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet. 2021;108:1251–69.
Article CAS PubMed PubMed Central Google Scholar
Staiger D, work(s): JHSR. Instrumental variables regression with weak instruments. Econometrica. 1997;65:557–86.
Burgess S. Online sample size and power calculator for Mendelian randomization with a binary outcome. https://sb452.shinyapps.io/power/. Accessed 30 Sep 2022.
Burgess S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43:922–9.
Article PubMed PubMed Central Google Scholar
Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100:9440–5.
留言 (0)